Erman Akkuş

413 total citations
30 papers, 248 citations indexed

About

Erman Akkuş is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Erman Akkuş has authored 30 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Erman Akkuş's work include SARS-CoV-2 and COVID-19 Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Erman Akkuş is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Diabetes Treatment and Management (3 papers). Erman Akkuş collaborates with scholars based in Türkiye, Spain and United States. Erman Akkuş's co-authors include Ayşegül Durak, Erkan Tuncay, Belma Turan, Yusuf Olğar, Yüksel Ürün, Güngör Utkan, Demet Çorapçıoğlu, Yang Jin, Nermin Kahraman and Partha P. Banerjee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Erman Akkuş

22 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erman Akkuş Türkiye 6 122 87 64 58 30 30 248
Cecilia Frej Sweden 6 196 1.6× 45 0.5× 68 1.1× 39 0.7× 28 0.9× 7 311
Kangyun Sun China 10 151 1.2× 82 0.9× 57 0.9× 83 1.4× 40 1.3× 15 293
Dyonne Vos Netherlands 5 139 1.1× 150 1.7× 104 1.6× 107 1.8× 29 1.0× 6 326
Haïfa Sanhaji Tunisia 12 69 0.6× 37 0.4× 46 0.7× 83 1.4× 18 0.6× 36 319
Eva Cecilie Knudsen Norway 9 76 0.6× 78 0.9× 28 0.4× 101 1.7× 34 1.1× 13 237
Xinbo Zhang United States 6 128 1.0× 45 0.5× 59 0.9× 57 1.0× 46 1.5× 13 287
A Hayward United Kingdom 6 102 0.8× 70 0.8× 66 1.0× 26 0.4× 20 0.7× 11 364
Sayumi Toriyama Japan 9 96 0.8× 33 0.4× 45 0.7× 35 0.6× 28 0.9× 12 245
Kelly Kernan United States 8 111 0.9× 32 0.4× 49 0.8× 17 0.3× 20 0.7× 10 240
Sylwia Górczyńska-Kosiorz Poland 11 96 0.8× 73 0.8× 150 2.3× 29 0.5× 16 0.5× 36 295

Countries citing papers authored by Erman Akkuş

Since Specialization
Citations

This map shows the geographic impact of Erman Akkuş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erman Akkuş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erman Akkuş more than expected).

Fields of papers citing papers by Erman Akkuş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erman Akkuş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erman Akkuş. The network helps show where Erman Akkuş may publish in the future.

Co-authorship network of co-authors of Erman Akkuş

This figure shows the co-authorship network connecting the top 25 collaborators of Erman Akkuş. A scholar is included among the top collaborators of Erman Akkuş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erman Akkuş. Erman Akkuş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akkuş, Erman & Ángela Lamarca. (2025). Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III randomized controlled trials. European Journal of Cancer. 220. 115342–115342. 3 indexed citations
2.
Akkuş, Erman & Alex Lyakhovich. (2025). Targeting the bioenergetics of a resistant tumor: clinical insights into OXPHOS inhibition for cancer therapy. SHILAP Revista de lepidopterología. 2025(1).
3.
Caturano, Alfredo, Enes Erul, Vincenzo Russo, et al.. (2025). Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad. European Journal of Clinical Investigation. 56(1). e70132–e70132.
4.
Akkuş, Erman, et al.. (2025). Stage‐specific characterization of “early‐onset colorectal cancer”: Localized and synchronous metastatic disease. International Journal of Cancer. 156(12). 2340–2351. 1 indexed citations
7.
Akkuş, Erman, Emre Yekedüz, & Yüksel Ürün. (2025). Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma. Clinical Genitourinary Cancer. 23(2). 102314–102314.
9.
Akkuş, Erman, Antonella Cammarota, Laura Izquierdo‐Sánchez, et al.. (2025). Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis. JHEP Reports. 8(1). 101613–101613.
10.
Akkuş, Erman, Çağatay Arslan, & Yüksel Ürün. (2024). Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectives. Cancer Treatment Reviews. 130. 102818–102818. 6 indexed citations
11.
Akkuş, Erman, Ayşe Salihoğlu, Ömür Gökmen Sevindik, et al.. (2024). P-194 A Germline Variant of BNIP1 Gene (rs28199) is Associated with Familial Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 24. S149–S150. 1 indexed citations
12.
Akkuş, Erman, Cihangir Akyol, Ali Ekrem Ünal, et al.. (2024). Types and Rates of COVID-19 Vaccination in Patients With Newly Diagnosed Microsatellite Stable and Instable Non-Metastatic Colon Cancer. Cureus. 16(6). e61780–e61780. 1 indexed citations
13.
Akkuş, Erman, et al.. (2024). Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study. Clinical & Translational Oncology. 27(5). 2292–2306. 1 indexed citations
14.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
15.
Özgür, Erol, Bülend Ortaç, İrem Akdemir Kalkan, et al.. (2023). Clinical evaluation of DIAGNOVIR SARS-CoV-2 ultra-rapid antigen test performance compared to PCR-based testing. Scientific Reports. 13(1). 4438–4438. 5 indexed citations
16.
Akkuş, Erman, et al.. (2021). Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data. Dermatologic Therapy. 34(6). e15122–e15122. 3 indexed citations
17.
Akkuş, Erman, et al.. (2020). Mean platelet volume and response to the first line therapy in newly diagnosed adult immune thrombocytopenia patients: a retrospective study. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(4). 798–803. 5 indexed citations
18.
Atilla, Pınar Ataca, Erman Akkuş, Erden Atilla, et al.. (2020). Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Transfusion Clinique et Biologique. 27(3). 115–121. 7 indexed citations
19.
Pällmann, Nora, Martina Tesikova, Hatice Zeynep Nenseth, et al.. (2019). Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer. Oncogene. 38(35). 6301–6318. 41 indexed citations
20.
Öcal, Lütfi, et al.. (2014). Unusual presentation of a recurrent squamous cell lung cancer. QJM. 108(3). 231–232.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026